In 197 patients with locally excised high-risk pT1/low-risk pT2 rectal cancer, adjuvant chemoradiotherapy failed non-inferiority to completion TME for estimated 3-year locoregional recurrence (5.0% vs 1.1%), but 3-year stoma rates were far lower (2.6% vs 45.4%).
RCTn = 197
Moolenaar et al. Adjuvant chemoradiotherapy versus completion total mesorectal excision after local excision for early rectal cancer (TESAR): a multicentre, randomised, controlled, phase 3, non-inferiority trial